Fear of hypoglycemia in adults with diabetes mellitus switching to treatment with IDegAsp co-formulation to examine real-world setting: an observational study (The HATICE study)
Open Access
- 21 October 2020
- journal article
- research article
- Published by Walter de Gruyter GmbH in Drug Metabolism and Personalized Therapy
- Vol. -1 (ahead-of-p)
Abstract
Objectives: To evaluate the clinical results of insulin degludec/aspart (IDEgAsp) therapy and its effect on the fear of hypoglycemia. Methods: A prospective observational study has been conducted through surveys of 36 patients using insulin because of type 2 diabetes mellitus who initiated treatment with IDegAsp switching from other insulins. Patients, 18–75 years old, were recruited to the study, consecutively. Participants’ age, gender, height, weight, body mass index (BMI), daily insulin dose, glycated hemoglobin (HbA1c), hypoglycemia rate, hypoglycemia fear survey (HFS) were recorded at the beginning of the study. By the end of 12th month, data was re-measured and compared with each other. Results: HbA1c was declined by mean of −1.59% (95% CI −1.06 to −2.12, p1c, less injection administration, and decreased the fear of hypoglycemia in diabetics.Keywords
This publication has 22 references indexed in Scilit:
- The Clinical Role of Insulin Degludec/Insulin Aspart in Type 2 Diabetes: An Empirical Perspective from Experience in AustraliaJournal of Clinical Medicine, 2020
- Effects of Daily Low-Dose Date Consumption on Glycemic Control, Lipid Profile, and Quality of Life in Adults with Pre- and Type 2 Diabetes: A Randomized Controlled TrialNutrients, 2020
- Addition of a single short-acting insulin bolus to basal insulin-supported oral therapy: a systematic review of data on the basal-plus regimenBMJ Open Diabetes Research & Care, 2019
- Twice-daily insulin degludec/insulin aspart effectively improved morning and evening glucose levels and quality of life in patients previously treated with premixed insulin: an observational studyDiabetology & Metabolic Syndrome, 2018
- Efficacy and safety of premixed insulin analogs in Asian patients with type 2 diabetes: A systematic reviewJournal of Diabetes Investigation, 2017
- 2. Classification and Diagnosis of DiabetesDiabetes Care, 2016
- Twice‐daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin‐naïve adults with Type 2 diabetesDiabetic Medicine, 2015
- The role of FOXO1 in β-cell failure and type 2 diabetes mellitusNature Reviews Endocrinology, 2013
- Hypoglycemia Fear and Self-efficacy of Turkish Patients Receiving Insulin TherapyAsian Nursing Research, 2011
- Fear of Hypoglycemia: Quantification, Validation, and UtilizationDiabetes Care, 1987